基于circRNA的治疗方法:神经炎症治疗的新前沿
Thikra Majid Muhammed1, Saade Abdalkareem Jasim2, Subasini Uthirapathy3
1Biology Department, College of Education for Pure Sciences, University of Anbar, Ramadi, Iraq.
Molecular neurobiology
|August 1, 2025
概括
循环RNAs (circRNAs) 在通过沉默或过度表达特定分子来治疗神经炎症方面表现有前途. 这些RNA分子提供了潜在的神经元保护,防止中枢神经系统的侮辱.
科学领域:
- 神经科学和分子生物学
- 研究圆形RNAs在中枢神经系统炎症中的作用.
背景情况:
- 神经炎症是中枢神经系统 (CNS) 中的一个复杂的反应,与神经系统疾病有关.
- 循环RNAs (circRNAs) 正在成为神经炎症疾病的关键调节剂,呈现出新的治疗点.
研究的目的:
- 提供关于神经炎症circRNA调制的当前研究的全面概述.
- 审查circRNA作用机制及其在神经炎症环境中的治疗潜力.
主要方法:
- 审查使用circRNA沉默 (siRNA,shRNA) 和过度表达 (等离子体,模仿转染) 策略的研究.
- 分析特定的circRNAs (例如,circHIPK2,circMETTL9,circCDC14A,circ_DLGAP4) 和它们的向生物分子 (例如,STAT3,p38 MAPK,NF-κB).
主要成果:
- 沉默circRNAs可以调节STAT3,化学激素和p38 MAPK,影响神经炎症.
- 循环RNAs的过度表达可以通过向NF-κB和HSP90.0来增强抗炎作用.
- 特定的circRNA介导轴 (例如circ-Shank3/TLR4) 影响神经炎症调节.
结论:
- 循环RNAs是神经炎症疾病治疗干预的有希望的途径.
- 了解circRNA调节机制对于开发有效的神经保护策略至关重要.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
235
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
235
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
271
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
271
Inflammatory Bowel Disease IV: Pharmacological Management
193
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
193
Microorganisms in Medicine and Therapeutics
345
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
345
NF-κB-dependent Signaling Pathway
7.9K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.9K
Inflammation
55.2K
Overview
55.2K


